Report Detail
Global (United States, European Union and China) Cardiovascular Drug Market Research Report 2019-2025
- RnM3578834 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Cardiovascular disease (CVD) is a major cause of death in the U.S. and rest of the world. These diseases are primarily related with heart and blood vessels disorders, such asischemic heart disease, dyslipidemia, stroke, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease and others. These disorders are mainly reported due to obesity, high cholesterol, smoking, excessi alcohol, and poor lifestyle.
The hypertension segment recorded $64.9 billion in sales in 2009. By a large margin, hypertension is the largest segment within the cardiovascular market, driven by a large number of billion-dollar-plus therapies.
In 2019, the market size of Cardiovascular Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cardiovascular Drug.
This report studies the global market size of Cardiovascular Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cardiovascular Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Amgen
AstraZeneca
Bayer
Bristol Myers Squibb and Pfizer
Daiichi Sankyo
Johnson & Johnson
Merck & Co.
Novartis
Pfizer
Portola
Sanofi
Market Segment by Product Type
heparin
Coumadin
Sectral
Zebeta
Lopressor
Toprol XL
Norvasc
Lotrel
Market Segment by Application
Hospital
Clinic
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cardiovascular Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cardiovascular Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cardiovascular Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cardiovascular Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 heparin
- 1.3.3 Coumadin
- 1.3.4 Sectral
- 1.3.5 Zebeta
- 1.3.6 Lopressor
- 1.3.7 Toprol XL
- 1.3.8 Norvasc
- 1.3.9 Lotrel
- 1.4 Market Segment by Application
- 1.4.1 Global Cardiovascular Drug Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Cardiovascular Drug Market Size
- 2.1.1 Global Cardiovascular Drug Revenue 2014-2025
- 2.1.2 Global Cardiovascular Drug Sales 2014-2025
- 2.2 Cardiovascular Drug Growth Rate by Regions
- 2.2.1 Global Cardiovascular Drug Sales by Regions 2014-2019
- 2.2.2 Global Cardiovascular Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Cardiovascular Drug Sales by Manufacturers
- 3.1.1 Cardiovascular Drug Sales by Manufacturers 2014-2019
- 3.1.2 Cardiovascular Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Cardiovascular Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Cardiovascular Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cardiovascular Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Cardiovascular Drug Price by Manufacturers
- 3.4 Key Manufacturers Cardiovascular Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cardiovascular Drug Market
- 3.6 Key Manufacturers Cardiovascular Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 heparin Sales and Revenue (2014-2019)
- 4.1.2 Coumadin Sales and Revenue (2014-2019)
- 4.1.3 Sectral Sales and Revenue (2014-2019)
- 4.1.4 Zebeta Sales and Revenue (2014-2019)
- 4.1.5 Lopressor Sales and Revenue (2014-2019)
- 4.1.6 Toprol XL Sales and Revenue (2014-2019)
- 4.1.7 Norvasc Sales and Revenue (2014-2019)
- 4.1.8 Lotrel Sales and Revenue (2014-2019)
- 4.2 Global Cardiovascular Drug Sales Market Share by Type
- 4.3 Global Cardiovascular Drug Revenue Market Share by Type
- 4.4 Cardiovascular Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cardiovascular Drug Sales by Application
6 United States
- 6.1 United States Cardiovascular Drug Breakdown Data by Company
- 6.2 United States Cardiovascular Drug Breakdown Data by Type
- 6.3 United States Cardiovascular Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Cardiovascular Drug Breakdown Data by Company
- 7.2 European Union Cardiovascular Drug Breakdown Data by Type
- 7.3 European Union Cardiovascular Drug Breakdown Data by Application
8 China
- 8.1 China Cardiovascular Drug Breakdown Data by Company
- 8.2 China Cardiovascular Drug Breakdown Data by Type
- 8.3 China Cardiovascular Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Cardiovascular Drug Breakdown Data by Company
- 9.2 Rest of World Cardiovascular Drug Breakdown Data by Type
- 9.3 Rest of World Cardiovascular Drug Breakdown Data by Application
- 9.4 Rest of World Cardiovascular Drug Breakdown Data by Countries
- 9.4.1 Rest of World Cardiovascular Drug Sales by Countries
- 9.4.2 Rest of World Cardiovascular Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Amgen
- 10.1.1 Amgen Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Cardiovascular Drug
- 10.1.4 Cardiovascular Drug Product Introduction
- 10.1.5 Amgen Recent Development
- 10.2 AstraZeneca
- 10.2.1 AstraZeneca Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Cardiovascular Drug
- 10.2.4 Cardiovascular Drug Product Introduction
- 10.2.5 AstraZeneca Recent Development
- 10.3 Bayer
- 10.3.1 Bayer Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Cardiovascular Drug
- 10.3.4 Cardiovascular Drug Product Introduction
- 10.3.5 Bayer Recent Development
- 10.4 Bristol Myers Squibb and Pfizer
- 10.4.1 Bristol Myers Squibb and Pfizer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Cardiovascular Drug
- 10.4.4 Cardiovascular Drug Product Introduction
- 10.4.5 Bristol Myers Squibb and Pfizer Recent Development
- 10.5 Daiichi Sankyo
- 10.5.1 Daiichi Sankyo Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Cardiovascular Drug
- 10.5.4 Cardiovascular Drug Product Introduction
- 10.5.5 Daiichi Sankyo Recent Development
- 10.6 Johnson & Johnson
- 10.6.1 Johnson & Johnson Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Cardiovascular Drug
- 10.6.4 Cardiovascular Drug Product Introduction
- 10.6.5 Johnson & Johnson Recent Development
- 10.7 Merck & Co.
- 10.7.1 Merck & Co. Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Cardiovascular Drug
- 10.7.4 Cardiovascular Drug Product Introduction
- 10.7.5 Merck & Co. Recent Development
- 10.8 Novartis
- 10.8.1 Novartis Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Cardiovascular Drug
- 10.8.4 Cardiovascular Drug Product Introduction
- 10.8.5 Novartis Recent Development
- 10.9 Pfizer
- 10.9.1 Pfizer Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Cardiovascular Drug
- 10.9.4 Cardiovascular Drug Product Introduction
- 10.9.5 Pfizer Recent Development
- 10.10 Portola
- 10.10.1 Portola Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Cardiovascular Drug
- 10.10.4 Cardiovascular Drug Product Introduction
- 10.10.5 Portola Recent Development
- 10.11 Sanofi
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Cardiovascular Drug Sales Channels
- 11.2.2 Cardiovascular Drug Distributors
- 11.3 Cardiovascular Drug Customers
12 Market Forecast
- 12.1 Global Cardiovascular Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Cardiovascular Drug Sales Forecast by Type
- 12.3 Global Cardiovascular Drug Sales Forecast by Application
- 12.4 Cardiovascular Drug Forecast by Regions
- 12.4.1 Global Cardiovascular Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Cardiovascular Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Cardiovascular Drug. Industry analysis & Market Report on Cardiovascular Drug is a syndicated market report, published as Global (United States, European Union and China) Cardiovascular Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cardiovascular Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
